Compare AURA & RMNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AURA | RMNI |
|---|---|---|
| Founded | 2007 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 396.8M | 351.4M |
| IPO Year | 2021 | N/A |
| Metric | AURA | RMNI |
|---|---|---|
| Price | $6.43 | $4.17 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 3 |
| Target Price | ★ $20.33 | $5.67 |
| AVG Volume (30 Days) | 200.9K | ★ 309.0K |
| Earning Date | 11-13-2025 | 10-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.47 |
| Revenue | N/A | ★ $425,959,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $3.13 |
| P/E Ratio | ★ N/A | $8.86 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.35 | $1.95 |
| 52 Week High | $9.14 | $5.38 |
| Indicator | AURA | RMNI |
|---|---|---|
| Relative Strength Index (RSI) | 60.80 | 58.77 |
| Support Level | $5.89 | $3.76 |
| Resistance Level | $6.53 | $3.89 |
| Average True Range (ATR) | 0.33 | 0.15 |
| MACD | 0.10 | 0.06 |
| Stochastic Oscillator | 86.21 | 94.65 |
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.
Rimini Street Inc and its subsidiaries are providers of end-to-end enterprise software support, products, and services. The Company offers a comprehensive family of unified solutions to run, manage, support, customize, configure, connect, protect, monitor, and optimize clients' enterprise applications, database, and technology software platforms. The Company derives revenues from clients by providing subscription support services for enterprise resource planning, customer relationship management, product lifecycle management database, and technology software systems. Geographically, the company generates the majority of its revenue from the United States of America and the International market.